Palmero Iii, Bernardo R.
HRN: 27-87-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/29/2025
10/06/2025
PO
4ml
TID
Amoebiasis
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes